CID 3010786

2-[5-(ethylamino)-1,3,4-thiadiazol-2-yl]benzenesulfonamide

Structural Information

Molecular Formula
C10H12N4O2S2
SMILES
CCNC1=NN=C(S1)C2=CC=CC=C2S(=O)(=O)N
InChI
InChI=1S/C10H12N4O2S2/c1-2-12-10-14-13-9(17-10)7-5-3-4-6-8(7)18(11,15)16/h3-6H,2H2,1H3,(H,12,14)(H2,11,15,16)
InChIKey
NRMCPOXVTWWEBL-UHFFFAOYSA-N
Compound name
2-[5-(ethylamino)-1,3,4-thiadiazol-2-yl]benzenesulfonamide
Related CIDs

2D Structure

compound 2d structure
1
Annotation Hits

1
References

0
Patents

284.04016 Da
Monoisotopic Mass

1.3
XlogP (predicted)

Profile

Predicted Collision Cross Section

Adduct m/z Predicted CCS (Ų)
[M+H]+ 285.04744 160.3
[M+Na]+ 307.02938 170.0
[M-H]- 283.03288 164.6
[M+NH4]+ 302.07398 175.3
[M+K]+ 323.00332 164.1
[M+H-H2O]+ 267.03742 153.2
[M+HCOO]- 329.03836 174.1
[M+CH3COO]- 343.05401 198.1
[M+Na-2H]- 305.01483 162.7
[M]+ 284.03961 162.1
[M]- 284.04071 162.1
m/z: mass to charge ratio of the adduct.
Predicted Collision Cross Section (CCS) values (Ų) per adduct calculated using CCSbase.

Literature stripe

literature stripe

Patent stripe

No patent data available for this compound.